Ardena | News & Insights

News
28.06.2022

Ardena’s customer Vicore Pharma initiates clinical trials with a new drug

Read more

NewsPress Release
06.05.2022

Ardena confirms spray drying upgrade and additional capabilities at Spanish site

Read more
Ardena joins DCAT and participates in DCAT Week 2022 featured image

News
03.03.2022

Ardena joins DCAT and participates in DCAT Week 2022

Read more
Ardena expands capacity to satisfy Novavax COVID vaccine demand featured image

Press Release
27.12.2021

Ardena expands capacity to satisfy Novavax COVID vaccine demand

Read more
Parvus Therapeutics and Ardena Enter Agreement for Tech Transfer, Scale-Up and GMP Manufacturing of Navacim Nanoparticles featured image

Press Release
25.11.2021

Parvus Therapeutics and Ardena Enter Agreement for Tech Transfer, Scale-Up and GMP Manufacturing of Navacim Nanoparticles

Read more

News
10.11.2021

Ardena’s customer Revolo starts new clinical trials

Read more
Steve Kendall, Ph.D. MBA, new Ardena Director of Business Development US. featured image

News
11.10.2021

Steve Kendall, Ph.D. MBA, new Ardena Director of Business Development US.

Read more
Ardena acquires Idifarma from Suanfarma, adding spray drying technology and high potency capabilities featured image

Press Release
01.09.2021

Ardena acquires Idifarma from Suanfarma, adding spray drying technology and high potency capabilities

Read more
Ardena’s expertise on drug substance development helps new treatment for Parkinson’s disease to the next phase featured image

Press Release
30.08.2021

Ardena’s expertise on drug substance development helps new treatment for Parkinson’s disease to the next phase

Read more
Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands featured image

Press Release
14.07.2021

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

Read more